•
Dec 31, 2022

ImmunityBio Q4 2022 Earnings Report

Total Revenue
$73K
Previous year: $390K
-81.3%
EPS
-$0.27
Previous year: -$0.23
+17.4%
Gross Profit
-$6.81M
Previous year: $390K
-1844.9%
Cash and Equivalents
$105M
Previous year: $181M
-42.2%
Free Cash Flow
-$110M
Previous year: -$82M
+33.7%
Total Assets
$362M
Previous year: $469M
-22.7%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment